EMS stocks surge as Apple plans to ship more India-made iPhones to the US
Team Finance Saathi
08/Apr/2025

What's covered under the Article:
-
EMS stocks including PG Electroplast and Kaynes Technology surged up to 9% on hopes of more Apple orders.
-
Apple eyes India-made iPhones for US exports to avoid steep tariffs on Chinese goods.
-
US-China trade war escalation drives Apple to expand its India-based supply chain with Foxconn and Tata.
In a significant development amid intensifying US-China trade tensions, Apple Inc. is reportedly planning to ramp up exports of India-manufactured iPhones to the United States. This move is seen as a strategic attempt to bypass the hefty tariffs imposed on Chinese imports. The development has sparked a surge in Indian EMS (Electronics Manufacturing Services) stocks during the April 8 trading session, with top players like PG Electroplast, Kaynes Technology, Dixon Technologies, and Syrma SGS Technology recording impressive gains.
Apple’s Tactical Move: From China to India
According to a report by The Wall Street Journal, Apple is considering India as a temporary manufacturing hub for iPhones destined for the US. The strategy is expected to help the tech giant sidestep the rising tariffs levied on Chinese imports by the US administration.
Apple's iPhone production partners in India include Foxconn and the Tata Group, both of which are expected to expand their supply chain capabilities to meet the growing export demand.
This pivot is not just about tariffs—it reflects a broader push by Apple to de-risk its over-dependence on China amidst growing geopolitical and economic uncertainties.
EMS Stocks React Positively
News of Apple's intentions had an immediate and positive impact on EMS stocks in India. Investors reacted optimistically to the prospects of increased order volumes, better margins, and enhanced visibility for companies serving the electronics manufacturing ecosystem.
-
PG Electroplast led the rally, surging 8.81% to an intraday high of Rs 884.65 on the NSE. The stock opened with a 4.62% gain, rebounding after a two-day decline.
-
Kaynes Technology India, another key EMS player, jumped 6.96% to Rs 4,748.25. It opened gap-up at 4.98%, recovering from a three-day fall.
-
Amber Enterprises and Dixon Technologies gained 6.04% and 5.45% respectively.
-
Syrma SGS Technology Ltd climbed 6.45% to Rs 444, after opening 5% higher.
The Trade War Trigger: High US Tariffs on China
The rally is rooted in developments from Washington. US President Donald Trump has announced multiple rounds of tariffs on Chinese goods, with a recent escalation:
-
A 34% tariff was announced on April 2.
-
An earlier 20% duty was already in place.
-
On April 7, Trump warned of another 50% tariff, which could take the total to 104% if fully implemented.
Beijing responded with a 34% retaliatory tariff on all US imports, leading to rising concerns about global supply chains and business continuity.
India’s Competitive Advantage: Lower Tariffs
While China bears the brunt of US trade policies, India’s relatively lower tariff of 26% makes it an attractive alternative. This cost arbitrage makes Indian-manufactured products more competitive in the US market and boosts the appeal of EMS companies operating out of India.
Apple, in a rush to beat a new tax deadline, recently flew five full planes loaded with iPhones and gadgets from India to the US within three days, highlighting the urgency and logistical preparedness for this shift.
Supply Chain Realignment on the Cards
For Apple to ramp up its exports from India, significant supply chain restructuring will be required. Partners like Foxconn and Tata Group will have to scale operations, ensure quality control, and maintain efficient logistics and compliance standards to meet the American market’s requirements.
This creates fresh growth opportunities for local EMS providers, who may benefit from new contracts, technology transfers, and long-term partnerships.
Strategic Implications for India
This development has far-reaching implications:
-
India cements its position as a global manufacturing alternative to China.
-
EMS companies stand to gain not just from Apple but potentially other global firms seeking to diversify their manufacturing base.
-
It opens avenues for increased foreign investment, job creation, and technological advancements in India's electronics sector.
This aligns with the Indian government’s ‘Make in India’ and ‘Production-Linked Incentive (PLI)’ schemes aimed at boosting local manufacturing capabilities.
Market Outlook: Short-Term Gains, Long-Term Promise
While the EMS rally is partly driven by speculation and sentiment, analysts believe the trend has solid long-term fundamentals. With Apple’s history of carefully planned supply chain strategies, the likelihood of continued engagement with Indian EMS players remains high.
However, risks remain. Geopolitical developments, logistics challenges, and policy uncertainties can affect execution timelines. Still, the positive investor sentiment and realignment of global trade routes signal a strong growth phase for Indian EMS companies.
Conclusion
The stock market rally of EMS companies like PG Electroplast, Kaynes Technology, Dixon Technologies, Amber Enterprises, and Syrma SGS Technology is a direct consequence of Apple’s shifting manufacturing strategy in response to the US-China trade war.
As India emerges as a strategic partner for global tech firms, the country’s electronics manufacturing ecosystem is poised for substantial growth. This realignment is not only a win for India’s industrial policy but also a sign of changing global supply chain dynamics in a post-pandemic, tariff-driven world.
The coming months will be critical in watching how Apple’s move plays out, and how Indian EMS companies scale up to meet global demands. Investors and policymakers alike will be closely tracking developments in this evolving story of global trade, technology, and geopolitical strategy.
The Upcoming IPOs in this week and coming weeks are Aten Papers & Foam.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.